-
1
-
-
78549254139
-
Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: Fibroblast-like synoviocytes as a potential source of extracellular survivin
-
Ahn JK, Oh JM, Lee J, Bae EK, Ahn KS, Cha HS, Koh EM. Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin. Inflammation 33: 381-388, 2010.
-
(2010)
Inflammation
, vol.33
, pp. 381-388
-
-
Ahn, J.K.1
Oh, J.M.2
Lee, J.3
Bae, E.K.4
Ahn, K.S.5
Cha, H.S.6
Koh, E.M.7
-
2
-
-
77956680686
-
Survivin and IAP proteins in cell-death mechanisms
-
Altieri DC. Survivin and IAP proteins in cell-death mechanisms. Biochem J 430: 199-205, 2010.
-
(2010)
Biochem J
, vol.430
, pp. 199-205
-
-
Altieri, D.C.1
-
3
-
-
0031576218
-
Characterization of an epithelial ~460-kDa protein that facilitates endocytosis of intrinsic factor-vitamin B12 and binds receptorassociated protein
-
Birn H, Verroust PJ, Nexo E, Hager H, Jacobsen C, Christensen EI, Moestrup SK. Characterization of an epithelial ~460-kDa protein that facilitates endocytosis of intrinsic factor-vitamin B12 and binds receptorassociated protein. J Biol Chem 272: 26497-26504, 1997.
-
(1997)
J Biol Chem
, vol.272
, pp. 26497-26504
-
-
Birn, H.1
Verroust, P.J.2
Nexo, E.3
Hager, H.4
Jacobsen, C.5
Christensen, E.I.6
Moestrup, S.K.7
-
4
-
-
70349567495
-
Receptor-mediated endocytosis in renal proximal tubule
-
Christensen EI, Verroust PJ, Nielsen R. Receptor-mediated endocytosis in renal proximal tubule. Pflügers Arch 58: 1039-1048, 2009.
-
(2009)
Pflügers Arch
, vol.58
, pp. 1039-1048
-
-
Christensen, E.I.1
Verroust, P.J.2
Nielsen, R.3
-
6
-
-
76749118103
-
Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer
-
Giaccone G, Zatloukal P, Roubec J, Floor K, Musil J, Kuta M, van Klaveren RJ, Chaudhary S, Gunther A, Shamsili S. Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer. J Clin Oncol 27: 4481-4486, 2009.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4481-4486
-
-
Giaccone, G.1
Zatloukal, P.2
Roubec, J.3
Floor, K.4
Musil, J.5
Kuta, M.6
van Klaveren, R.J.7
Chaudhary, S.8
Gunther, A.9
Shamsili, S.10
-
7
-
-
78751632457
-
Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma
-
Herrington WG, Talbot DC, Lahn MM, Brandt JT, Callies S, Nagle R, Winearls CG, Roberts IS. Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma. Am J Kidney Dis 57: 300-303, 2011.
-
(2011)
Am J Kidney Dis
, vol.57
, pp. 300-303
-
-
Herrington, W.G.1
Talbot, D.C.2
Lahn, M.M.3
Brandt, J.T.4
Callies, S.5
Nagle, R.6
Winearls, C.G.7
Roberts, I.S.8
-
8
-
-
34547549299
-
Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculoacoustico- renal syndromes
-
Kantarci S, Al-Gazali L, Hill RS, Donnai D, Black GC, Bieth E, Chassaing N, Lacombe D, Devriendt K, Teebi A, Loscertales M, Robson C, Liu T, MacLaughlin DT, Noonan KM, Russell MK, Walsh CA, Donahoe PK, Pober BR. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculoacoustico- renal syndromes. Nat Genet 39: 957-959, 2007.
-
(2007)
Nat Genet
, vol.39
, pp. 957-959
-
-
Kantarci, S.1
Al-Gazali, L.2
Hill, R.S.3
Donnai, D.4
Black, G.C.5
Bieth, E.6
Chassaing, N.7
Lacombe, D.8
Devriendt, K.9
Teebi, A.10
Loscertales, M.11
Robson, C.12
Liu, T.13
Maclaughlin, D.T.14
Noonan, K.M.15
Russell, M.K.16
Walsh, C.A.17
Donahoe, P.K.18
Pober, B.R.19
-
9
-
-
79951551519
-
Survivin is released from cancer cells via exosomes
-
Khan S, Jutzy JM, Aspe JR, McGregor DW, Neidigh JW, Wall NR. Survivin is released from cancer cells via exosomes. Apoptosis 16: 1-12, 2011.
-
(2011)
Apoptosis
, vol.16
, pp. 1-12
-
-
Khan, S.1
Jutzy, J.M.2
Aspe, J.R.3
McGregor, D.W.4
Neidigh, J.W.5
Wall, N.R.6
-
10
-
-
38949146336
-
Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure
-
Kindt N, Menzebach A, Van de Wouwer M, Betz I, De Vriese A, Conway EM. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J 22: 510-521, 2008.
-
(2008)
FASEB J
, vol.22
, pp. 510-521
-
-
Kindt, N.1
Menzebach, A.2
Van de Wouwer, M.3
Betz, I.4
de Vriese, A.5
Conway, E.M.6
-
11
-
-
77649171248
-
Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: Modulation by hypoxia
-
Kroening S, Neubauer E, Wullich B, Aten J, Goppelt-Struebe M. Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. Am J Physiol Renal Physiol 298: F796-F806, 2010.
-
(2010)
Am J Physiol Renal Physiol
, vol.298
-
-
Kroening, S.1
Neubauer, E.2
Wullich, B.3
Aten, J.4
Goppelt-Struebe, M.5
-
12
-
-
36349015992
-
The tumor gene survivin is highly expressed in adult renal tubular cells: Implications for a pathophysiological role in the kidney
-
Lechler P, Wu X, Bernhardt W, Campean V, Gastiger S, Hackenbeck T, Klanke B, Weidemann A, Warnecke C, Amann K, Engehausen D, Willam C, Eckardt K, Rödel F, Wiesener M. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am J Pathol 171: 1483-1498, 2007.
-
(2007)
Am J Pathol
, vol.171
, pp. 1483-1498
-
-
Lechler, P.1
Wu, X.2
Bernhardt, W.3
Campean, V.4
Gastiger, S.5
Hackenbeck, T.6
Klanke, B.7
Weidemann, A.8
Warnecke, C.9
Amann, K.10
Engehausen, D.11
Willam, C.12
Eckardt, K.13
Rödel, F.14
Wiesener, M.15
-
13
-
-
79151481416
-
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
-
Lewis KD, Samlowski W, Ward J, Catlett J, Cranmer L, Kirkwood J, Lawson D, Whitman E, Gonzalez R. A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma. Invest New Drugs 29: 161-166, 2011.
-
(2011)
Invest New Drugs
, vol.29
, pp. 161-166
-
-
Lewis, K.D.1
Samlowski, W.2
Ward, J.3
Catlett, J.4
Cranmer, L.5
Kirkwood, J.6
Lawson, D.7
Whitman, E.8
Gonzalez, R.9
-
14
-
-
0034091428
-
Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli
-
Lorz C, Ortiz A, Justo P, Gonzalez-Cuadrado S, Duque N, Gomez- Guerrero C, Egido J. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 11: 1266-1277, 2000.
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 1266-1277
-
-
Lorz, C.1
Ortiz, A.2
Justo, P.3
Gonzalez-Cuadrado, S.4
Duque, N.5
Gomez-Guerrero, C.6
Egido, J.7
-
15
-
-
83655199374
-
The role of survivin in diagnosis, prognosis and treatment of breast cancer
-
Lv YG, Yu F, Yao Q, Chen JH, Wang L. The role of survivin in diagnosis, prognosis and treatment of breast cancer. J Thorac Dis 2: 100-110, 2010.
-
(2010)
J Thorac Dis
, vol.2
, pp. 100-110
-
-
Lv, Y.G.1
Yu, F.2
Yao, Q.3
Chen, J.H.4
Wang, L.5
-
16
-
-
0032148360
-
Beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein- I-phospholipid complex harbor a recognition site for the endocytic receptor megalin
-
Moestrup SK, Schousboe I, Jacobsen C, Leheste JR, Christensen EI, Willnow TE. Beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein- I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. J Clin Invest 102: 902-909, 1998.
-
(1998)
J Clin Invest
, vol.102
, pp. 902-909
-
-
Moestrup, S.K.1
Schousboe, I.2
Jacobsen, C.3
Leheste, J.R.4
Christensen, E.I.5
Willnow, T.E.6
-
17
-
-
15444347159
-
Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta
-
Moser M, Pscherer A, Roth C, Becker J, Mucher G, Zerres K, Dixkens C, Weis J, Guay-Woodford L, Buettner R, Fassler R. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Genes Dev 11: 1938-1948, 1997.
-
(1997)
Genes Dev
, vol.11
, pp. 1938-1948
-
-
Moser, M.1
Pscherer, A.2
Roth, C.3
Becker, J.4
Mucher, G.5
Zerres, K.6
Dixkens, C.7
Weis, J.8
Guay-Woodford, L.9
Buettner, R.10
Fassler, R.11
-
18
-
-
0028456132
-
Proliferative activity of intrinsic cell populations in the normal human kidney
-
Nadasdy T, Laszik Z, Blick KE, Johnson LD, Silva FG. Proliferative activity of intrinsic cell populations in the normal human kidney. J Am Soc Nephrol 4: 2032-2039, 1994.
-
(1994)
J Am Soc Nephrol
, vol.4
, pp. 2032-2039
-
-
Nadasdy, T.1
Laszik, Z.2
Blick, K.E.3
Johnson, L.D.4
Silva, F.G.5
-
19
-
-
0033582543
-
An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3
-
Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507-515, 1999.
-
(1999)
Cell
, vol.96
, pp. 507-515
-
-
Nykjaer, A.1
Dragun, D.2
Walther, D.3
Vorum, H.4
Jacobsen, C.5
Herz, J.6
Melsen, F.7
Christensen, E.I.8
Willnow, T.E.9
-
20
-
-
0035923688
-
Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3)
-
Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, Verroust PJ, Aminoff M, de la Chapelle A, Moestrup SK, Ray R, Gliemann J, Willnow TE, Christensen EI. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci USA 98: 13895-13900, 2001.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 13895-13900
-
-
Nykjaer, A.1
Fyfe, J.C.2
Kozyraki, R.3
Leheste, J.R.4
Jacobsen, C.5
Nielsen, M.S.6
Verroust, P.J.7
Aminoff, M.8
de la Chapelle, A.9
Moestrup, S.K.10
Ray, R.11
Gliemann, J.12
Willnow, T.E.13
Christensen, E.I.14
-
21
-
-
0642283959
-
Targeting apoptosis in acute tubular injury
-
Ortiz A, Justo P, Sanz A, Lorz C, Egido J. Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66: 1589-1594, 2003.
-
(2003)
Biochem Pharmacol
, vol.66
, pp. 1589-1594
-
-
Ortiz, A.1
Justo, P.2
Sanz, A.3
Lorz, C.4
Egido, J.5
-
22
-
-
66649126940
-
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors
-
Satoh T, Okamoto I, Miyazaki M, Morinaga R, Tsuya A, Hasegawa Y, Terashima M, Ueda S, Fukuoka M, Ariyoshi Y, Saito T, Masuda N, Watanabe H, Taguchi T, Kakihara T, Aoyama Y, Hashimoto Y, Nakagawa K. Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin Cancer Res 15: 3872-3880, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3872-3880
-
-
Satoh, T.1
Okamoto, I.2
Miyazaki, M.3
Morinaga, R.4
Tsuya, A.5
Hasegawa, Y.6
Terashima, M.7
Ueda, S.8
Fukuoka, M.9
Ariyoshi, Y.10
Saito, T.11
Masuda, N.12
Watanabe, H.13
Taguchi, T.14
Kakihara, T.15
Aoyama, Y.16
Hashimoto, Y.17
Nakagawa, K.18
-
23
-
-
0035900947
-
Urine detection of survivin and diagnosis of bladder cancer
-
Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC. Urine detection of survivin and diagnosis of bladder cancer. JAMA 285: 324-328, 2001.
-
(2001)
JAMA
, vol.285
, pp. 324-328
-
-
Smith, S.D.1
Wheeler, M.A.2
Plescia, J.3
Colberg, J.W.4
Weiss, R.M.5
Altieri, D.C.6
-
24
-
-
84874891861
-
Renal phenotypic investigations of megalin-deficient patients: Novel insights into tubular proteinuria and albumin filtration
-
Storm T, Tranebjærg L, Frykholm C, Birn H, Verroust PJ, Nevéus T, Sundelin B, Hertz JM, Holmström G, Ericson K, Christensen EI, Nielsen R. Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration. Nephrol Dial Transplant 28: 585-591, 2013.
-
(2013)
Nephrol Dial Transplant
, vol.28
, pp. 585-591
-
-
Storm, T.1
Tranebjærg, L.2
Frykholm, C.3
Birn, H.4
Verroust, P.J.5
Nevéus, T.6
Sundelin, B.7
Hertz, J.M.8
Holmström, G.9
Ericson, K.10
Christensen, E.I.11
Nielsen, R.12
-
25
-
-
84859422180
-
A phase II study of YM155, a novel smallmolecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
-
Tolcher AW, Quinn DI, Ferrari A, Ahmann F, Giaccone G, Drake T, Keating A, de Bono JS. A phase II study of YM155, a novel smallmolecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. Ann Oncol 23: 968-973, 2012.
-
(2012)
Ann Oncol
, vol.23
, pp. 968-973
-
-
Tolcher, A.W.1
Quinn, D.I.2
Ferrari, A.3
Ahmann, F.4
Giaccone, G.5
Drake, T.6
Keating, A.7
de Bono, J.S.8
-
26
-
-
0027427492
-
Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
-
Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240, 1993.
-
(1993)
Cell
, vol.75
, pp. 229-240
-
-
Veis, D.J.1
Sorenson, C.M.2
Shutter, J.R.3
Korsmeyer, S.J.4
-
27
-
-
0033923368
-
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement
-
Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T, Noel JP. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol 7: 602-608, 2000.
-
(2000)
Nat Struct Biol
, vol.7
, pp. 602-608
-
-
Verdecia, M.A.1
Huang, H.2
Dutil, E.3
Kaiser, D.A.4
Hunter, T.5
Noel, J.P.6
-
28
-
-
80155172527
-
Mouse model of proximal tubule endocytic dysfunction
-
Weyer K, Storm T, Shan J, Vainio S, Kozyraki R, Verroust PJ, Christensen EI, Nielsen R. Mouse model of proximal tubule endocytic dysfunction. Nephrol Dial Transplant 26: 3446-3451, 2011.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 3446-3451
-
-
Weyer, K.1
Storm, T.2
Shan, J.3
Vainio, S.4
Kozyraki, R.5
Verroust, P.J.6
Christensen, E.I.7
Nielsen, R.8
-
29
-
-
0029775625
-
Defective forebrain development in mice lacking gp330/megalin
-
Willnow TE, Hilpert J, Armstrong SA, Rohlmann A, Hammer RE, Burns DK, Herz J. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 93: 8460-8464, 1996.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 8460-8464
-
-
Willnow, T.E.1
Hilpert, J.2
Armstrong, S.A.3
Rohlmann, A.4
Hammer, R.E.5
Burns, D.K.6
Herz, J.7
|